Moffitt Cancer Center leads the way in revolutionizing cancer treatment with bioengineering

Bioengineering is revolutionizing cancer research, and Moffitt Cancer Center is at the forefront of this transformative movement. Moffitt is the first National Cancer Institute-designated comprehensive cancer center with a dedicated bioengineering department. This area of science integrates engineering and physical sciences with oncology to change how we understand and treat this complex disease. In a new commentary published in Cancer Cell, W. Gregory Sawyer, Ph.D., and Elsa R. Flores, Ph.D., share their visionary framework to accelerate cancer discovery and therapy breakthroughs through bioengineering.

Cancer's complexity has been a formidable obstacle for researchers. Traditional methods often struggle to capture the intricate interplay between cancer cells, the immune system and the surrounding environment. Cancer engineering offers a unique perspective by integrating these diverse fields, creating a powerful platform to develop next-generation solutions."

W. Gregory Sawyer, Ph.D., Chair of Moffitt's Department of Bioengineering

Cancer engineering blends 12 key fields, including system dynamics, nanomaterials, robotics, and biofabrication, to tackle cancer from all angles. This powerful platform could lead to advancements in early detection with microfluidic devices and advanced imaging techniques. Additionally, nanomaterials engineered on a microscopic level could revolutionize drug delivery by transporting medications directly to cancer cells with minimal impact on healthy tissues.

The potential doesn't stop there. 3D bioprinting technology offers the potential to create customized tumor models, allowing researchers to test drug efficacy and personalize treatment plans for individual patients. Sophisticated mathematical modeling, informed by engineering principles, could provide a deeper understanding of cancer's intricate biological processes, paving the way for developing more effective therapies.

"The possibilities unlocked by cancer engineering are truly exciting," said Flores, associate center director of Basic Science at Moffitt. "We envision more universities and cancer centers following Moffitt's lead and creating dedicated cancer engineering programs to foster collaboration and accelerate progress in the fight against cancer."

Journal reference:

Flores, E. R. & Sawyer, W. G., (2024) Engineering cancer’s end: An interdisciplinary approach to confront the complexities of cancer. Cancer Cell.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Does hormone-modulating therapy for breast cancer treatment affect risk for Alzheimer disease and related dementias?